Home
>
National Drug Code (NDC)
>
Bacteriostatic Sodium Chloride
Bacteriostatic Sodium Chloride - 63323-924-30 - (SODIUM CHLORIDE)
Drug Information of Bacteriostatic Sodium Chloride
| Product NDC: | 63323-924 |
| Proprietary Name: | Bacteriostatic Sodium Chloride |
| Non Proprietary Name: | SODIUM CHLORIDE |
| Active Ingredient(s): | 9 mg/mL & nbsp; SODIUM CHLORIDE |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Bacteriostatic Sodium Chloride
| Product NDC: | 63323-924 |
| Labeler Name: | APP Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA088911 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20000808 |
Package Information of Bacteriostatic Sodium Chloride
| Package NDC: | 63323-924-30 |
| Package Description: | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-924-30) > 30 mL in 1 VIAL, MULTI-DOSE |
NDC Information of Bacteriostatic Sodium Chloride
| NDC Code | 63323-924-30 |
| Proprietary Name | Bacteriostatic Sodium Chloride |
| Package Description | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-924-30) > 30 mL in 1 VIAL, MULTI-DOSE |
| Product NDC | 63323-924 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | SODIUM CHLORIDE |
| Dosage Form Name | INJECTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Start Marketing Date | 20000808 |
| Marketing Category Name | ANDA |
| Labeler Name | APP Pharmaceuticals, LLC |
| Substance Name | SODIUM CHLORIDE |
| Strength Number | 9 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |
